Cure My Disease

Don't miss your cure!

 Log in / Sign up

New clip tested in 250 patients to seal gut bleeds and tears

NCT ID NCT05852457

Disease control Sponsor: AdventHealth Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracks how well a device called the DAT clip works during routine endoscopy to stop bleeding, close perforations (holes), or treat fistulas (abnormal connections) in the digestive tract. Researchers will record data from 250 adults who need this clip as part of their standard care. The main goal is to see how often the clip fully closes the target area.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
DAT clip (a medical device used during endoscopy to close holes or stop bleeding)
What this could lead to
If successful, this could confirm that the DAT clip is a reliable tool for managing common GI emergencies like bleeding or perforations during routine procedures.
What could go wrong
This is an observational study, not a controlled trial, so results may not prove the clip is better than other methods. Success depends on the skill of the doctor and the specific case.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 250 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2022

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients scheduled to undergo endoscopic procedures at participating centers as medically indicated will be considered for the study.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older. * Patients scheduled to undergo endoscopic procedures as part of their routine care in which endoscopic clip closure is clinically indicated: Treatment of bleeding Treatment of perforation and/or fistulas Tissue approximation for mucosal gaps associated with endoscopic resection (e.g., endoscopic mucosal resection, endoscopic submucosal dissection) or third space endoscopy (e.g., peroral endoscopic myotomy in the gastrointestinal tract) Exclusion Criteria: * Any contraindications to performing endoscopy. * Participants in another research protocol that could interfere or influence the outcomes measures of the present study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fistula are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fistula Gastrointestinal Hemorrhage intestinal fistula intestinal perforation peptic ulcer perforation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fistula Gi bleeding Perforated bowel Perforation bowel Perforation colon Perforation duodenal

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AdventHealth Orlando

    RECRUITING

    Orlando, Florida, 32803, United States

  • Parkview Health

    RECRUITING

    Fort Wayne, Indiana, 46845, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.